Document is current
Any future updates will be listed below
-
Authors
Abe, Kazuya
Ishikawa, Yuichi http://orcid.org/0000-0001-7406-2309
Kita, Yasuhiko
Yajima, Nobuyuki
Inoue, Eisuke
Sada, Ken-ei
Miyawaki, Yoshia
Yoshimi, Ryusuke
Shimojima, Yasuhiro
Ohno, Shigeru
Kajiyama, Hiroshi
Ichinose, Kunihiro
Sato, Shuzo
Fujiwara, Michio
- License Information
-
More Information
Article History
Received: 22 October 2021
Accepted: 19 July 2022
First Online: 28 July 2022
Declarations
:
: Informed consent was obtained from all participants prior to enrollment in the study. Patient information was anonymized and de-identified prior to analysis. This study was conducted in accordance with the tenets of the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. The Ethics Committee of the Yokohama Rosai Hospital approved the study protocol (#31-35).
: Not applicable.
: RY received speaker’s fees from Sanofi K.K., GlaxoSmithKline K.K., Novartis Pharmaceuticals, AYUMI Pharmaceutical Corporation, and Astellas Pharma Inc. KS received speaker’s fee from Glaxo Smith Kline K.K. EI received speaker’s fees from Pfizer Japan Inc. and Bristol-Myers Squibb Company.
